In today’s recent session, 0.99 million shares of the Day One Biopharmaceuticals Inc (NASDAQ:DAWN) have been traded, and its beta is -1.24. Most recently the company’s share price was $6.55, and it changed around -$0.44 or -6.29% from the last close, which brings the market valuation of the company to $663.86M. DAWN at last check was trading at a discount to its 52-week high of $17.79, offering almost -171.6% off that amount. The share price’s 52-week low was $6.41, which indicates that the recent value has risen by an impressive 2.14% since then.
Day One Biopharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.22. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended DAWN as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) trade information
Instantly DAWN has been showing red trend so far today with a performance of -6.29% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.09 on recent trading dayincreased the stock’s daily price by 19.04%. The company’s shares are currently down -48.30% year-to-date, but still down -15.81% over the last five days. On the other hand, Day One Biopharmaceuticals Inc (NASDAQ:DAWN) is -6.70% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to increase their stock price by 83.62% from its current value. Analyst projections state that DAWN is forecast to be at a low of $24 and a high of $45.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -38.09%.
DAWN Dividends
Day One Biopharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, with 7.3808% or 6.43 million shares worth $88.61 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Securities Fund-Fidelity Small Cap Growth Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.24 shares worth $15.2 million, making up 2.21% of all outstanding shares. On the other hand, Fidelity Securities Fund-Fidelity Small Cap Growth Fund held roughly 1.59 shares worth around $10.82 million, which represents about 1.57% of the total shares outstanding.
